We did not start this brand because the world needed another body care line.
The cosmetics industry produces, by some count, around 6,000 new SKUs every year. The shelf is not undersupplied. Consumers are not under-marketed-to. There is no plausible argument that one more brand of refillable porcelain capsules is what the category was waiting for.
We started it because a particular collision interested us — the formulation discipline of Korean cosmetic chemistry meeting the botanical inheritance of Southern Africa, and what happened to a body care range when both of those traditions were taken seriously instead of one being decoration on top of the other.
Two industries, two relationships to the truth
K-beauty earned its reputation by closing a gap that the Western cosmetics industry had let widen for thirty years. Where European and American brands had grown comfortable with the marketing claim — infused with, enriched by, inspired by — Korean formulators stayed close to the chemistry. South Korean regulators expected supporting data. South Korean consumers expected texture, finish, and absorption that were technical outcomes, not marketing language. The result, by the early 2010s, was a manufacturing supply chain in Seoul and Suwon and Anyang that became the most rigorous in the world for new active deployment, microbiome-aware preservatives, peptide stabilisation, and the boring, expensive work of figuring out how a serum should feel between fingertips.
The South African cosmetic industry, by contrast, has spent its modern history with a different relationship to the truth — one rooted in plants. The Khoisan herbalists who first used buchu and rooibos and devil’s claw did not need a white paper to know what those plants did. The tradition came down through generations of direct, embodied experience. It was empirical in the older sense of the word: tested in bodies, over time, under pressure.
These are not the same kind of knowledge. They sit at different points on a long history of how human beings have come to know what is true about the materials we put on our skin. Both have a claim. Neither, on its own, is the whole picture.
The brand we wanted to build was the one that took both seriously — that asked Korean chemists to work with Southern African botanicals at evidence-supported concentrations in formulations that had been refined sensorially the way a face cream gets refined sensorially in Seoul. Not as accent ingredients. Not as marketing colour. As primary actives, doing the work that the chemistry says they can do.
Why this is not a face brand
We made an early decision not to build a face skincare line. The face skincare category is mature, crowded, and dominated by serious players. Anyone trying to enter it competes against twenty-year-formulation depth at La Mer, against the pricing chaos of The Ordinary, against the cultural saturation of K-beauty itself.
Body care is different. The category is — even in 2026 — under-serious. Most “luxury” body care is fragranced petroleum jelly in a heavy bottle. The actual peptide work, the actual ceramide chemistry, the actual barrier-respecting cleansing systems that face care has spent a decade refining have largely not made it across to body. There is room in body care for the work that we wanted to do.
There is also a more interesting argument underneath this — that the body has been treated as the afterthought of the skin, when it is in fact most of the skin. The face is roughly 4% of the body’s total skin surface. Most of what your skin is — most of where the barrier function is happening, most of where ageing is showing up, most of where ritual care actually plays out — is below the neck. The whole way the cosmetic industry has divided face from body is an artefact of historical price-point logic, not biology.
The plants
Every primary active in the launch range is indigenous to Southern Africa. Marula seed oil from the Eudafano Women’s Cooperative in northern Namibia. Rooibos from the Heiveld Co-op in the Cederberg. Honeybush from the Eastern Cape. Cape aloe ferox. Devil’s claw. Baobab. Buchu. Helichrysum. Rose geranium.
These are not exotic accents. They are the centre of the formulations. We chose them because their pharmacology is genuinely interesting — peer-reviewed RCT data on marula, polyphenol content in honeybush that exceeds green tea by some measures, the polysaccharide complexity of Aloe ferox that distinguishes it from the more common Aloe barbadensis. We also chose them because they let us work in a register that a Korea-only brand cannot. The Cape Floral Kingdom is not a marketing flourish. It is a UNESCO World Heritage biome containing roughly 9,000 plant species in 90,000 square kilometres, most of them found nowhere else on earth. There is real chemical novelty there.
We work with these botanicals under formal Nagoya Protocol and NEMBA benefit-sharing agreements. The communities of origin are partners, not suppliers. We mean that in the legal sense — the agreements route a defined portion of commercial value back to the source communities — and we mean it in the practical sense, that those communities have rights of consultation about how their traditional knowledge is described and used in our marketing.
This is the baseline for using indigenous Southern African plants in commercial cosmetics. The industry’s track record is uneven; we are clear-eyed about that. We are trying to be specific about which side of the line we are on.
What we are not
We are not a longevity clinic. We do not sell hope. We are not a celebrity brand. We are not a wellness brand in the diffuse, vibe-led sense that has come to dominate that word.
We are a body care company that takes the chemistry seriously enough to disclose concentrations, the sourcing seriously enough to name partner cooperatives, and the design of the object seriously enough to make a hand-poured porcelain capsule built to live on a bathroom shelf for years.
The format of this brand — the porcelain, the refills, the editorial register, the absence of an e-commerce funnel that pressures you toward a subscription — reflects our actual view of how a small cosmetics company should behave when it is being honest with itself.
What this letter is, and is not
This is not a press release. It is the closest thing we have to a public statement of why we are doing this work. There will be longer essays on each of the threads — the science, the policy, the aesthetic. They are in the Journal. If you read one thing after this letter, read the piece on the Nagoya Protocol.
If you have read this far, thank you.
— The Veldt & Vein team